LE/AF Purified Anti-Mouse CD19 Monoclonal Antibody [1D3]

  • Flow cytometry antibody-Elabscience
<
>
  • Flow cytometry antibody-Elabscience
  • Flow cytometry antibody-Elabscience
    产品货号:E-AB-F09860

    别称:B-lymphocyte antigen CD19,Cd19,Differentiation antigen CD19,CD19

    规格:
    • 50 μg
    • 500 μg
    • 1 mg
    数量:
    - +
    价格: ¥525

    Antigen Information

    Alternate Names B-lymphocyte antigen CD19,Cd19,Differentiation antigen CD19,CD19
    Uniprot ID P25918
    Background CD19 is a 95 kD glycoprotein also known as B4. It is a member of the Ig superfamily, expressed on all pro-B to mature B cells (during development) and follicular dendritic cells. Plasma cells do not express CD19. CD19, in association with CD21 and CD81, forms a molecular complex integral to B cell activation.

    Product Details

    Form Liquid
    Clone No. 1D3 (See Other Available Formats)
    Host Rat
    Isotype Rat IgG2a, κ
    Isotype Control LE/AF Purified Rat IgG2a, κ Isotype Control [2A3] [Product E-AB-F098330]
    Reactivity Mouse
    Application Cell Sep-Neg, Depletion, Neut, FCM, IP (See the Application Description)
    Storage Buffer 0.2 µm filtered in PBS, pH7.2. Contains no stabilizers or preservatives. Endotoxin level is < 2 EU/mg (<0.002EU/μg) as Determined by LAL gel clotting assay. Purity is >95% as determined by SDS-PAGE
    Shipping Biological ice pack at 4 ℃
    Stability & Storage Keep as concentrated solution.
    Store at 2~8℃ and protected from prolonged exposure to light. Do not freeze.
    Centrifuge before opening to ensure complete recovery of vial contents.
    This product is guaranteed up to one year from purchase.

    Fluorophore

    Conjugation: None(Low endotoxin/Azide Free)

    Recommended Use

    Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 µg per 106 cells in 100 µl volume or 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

    References

    1. Fearon DT. 1993. Curr. Opin. Immunol. 5:341.
    2. Krop I, et al. 1996. Eur. J. Immunol. 26:238.
    3. Krop I, et al. 1996. J. Immunol. 157:48.
    4. Tedder TF, et al. 1994. Immunol. Today 15:437.
    写评论得优惠
    • 全部 (0)
    • 评论 (0)
    • 问答 (0)
    ... 展开 收起

    我的购物车

    产品名称 数量 价格
    结算

    总计:

    抗体促销

    浏览历史


      买了该产品的人还买了